Effectiveness of the Quotient® ADHD Assessment in a System of Care
| Status: | Terminated |
|---|---|
| Conditions: | Cognitive Studies, Neurology, Psychiatric, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 6 - 12 |
| Updated: | 4/21/2016 |
| Start Date: | March 2014 |
| End Date: | August 2015 |
The study goal is to examine whether the use of an objective computerized neuroassessment
(the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to
improved outcomes among pediatric patients being assessed and treated for ADHD.
(the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to
improved outcomes among pediatric patients being assessed and treated for ADHD.
This study is a randomized, controlled trial using a 2-phase data collection. The first
phase is the initial assessment for ADHD and includes all patients eligible to be assessed
for ADHD as determined by their clinician in the course of usual care. The baseline
measurements will be used to compare groups at baseline, and also for longitudinal analyses
of medication management. Patients are randomized at this point. Patients in both treatment
arms who then receive an ADHD diagnosis and who start medication for ADHD will be eligible
for the second phase of the study: three follow-up assessments over six months. Patients who
do not have an ADHD diagnosis will not continue in the study, and will be treated by their
clinician as usual.
phase is the initial assessment for ADHD and includes all patients eligible to be assessed
for ADHD as determined by their clinician in the course of usual care. The baseline
measurements will be used to compare groups at baseline, and also for longitudinal analyses
of medication management. Patients are randomized at this point. Patients in both treatment
arms who then receive an ADHD diagnosis and who start medication for ADHD will be eligible
for the second phase of the study: three follow-up assessments over six months. Patients who
do not have an ADHD diagnosis will not continue in the study, and will be treated by their
clinician as usual.
Inclusion Criteria:
- All patients within the specified age range who are English speaking and who are
presenting for ADHD assessment are eligible. An additional criterion is consent to be
randomized.
Exclusion Criteria:
- Non English speaking
- Refusal to participate
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials